Literature DB >> 7815415

Anticipation resulting in elimination of the myotonic dystrophy gene: a follow up study of one extended family.

C E de Die-Smulders1, C J Höweler, J F Mirandolle, H G Brunner, V Hovers, H Brüggenwirth, H J Smeets, J P Geraedts.   

Abstract

We have re-examined an extended myotonic dystrophy (DM) family, previously described in 1955, in order to study the long term effects of anticipation in DM and in particular the implications for families affected by this disease. This follow up study provides data on 35 gene carriers and 46 asymptomatic at risk family members in five generations. Clinical anticipation, defined as the cascade of mild, adult, childhood, or congenital disease in subsequent generations, appeared to be a relentless process, occurring in all affected branches of the family. The cascade was found to proceed asynchronously in the different branches, mainly because of an unequal number of generations with mild disease. The transition from the mild to the adult type was associated with transmission through a male parent. Stable transmission of the asymptomatic/mild phenotype showed a female transmission bias. We further examined the extent and causes of gene loss in this pedigree. Gene loss in the patient group was complete, owing to infertility of the male patients with adult onset disease and the fact that mentally retarded patients did not procreate. Out of the 46 at risk subjects in the two youngest generations, only one was found to have a full mutation. This is the only subject who may transmit the gene to the sixth generation. No protomutation carriers were found in the fourth and fifth generations. Therefore it is highly probable that the DM gene will be eliminated from this pedigree within one generation. The high population frequency of DM can at present not be explained by the contribution of asymptomatic cases in the younger generations of known families, but is probably caused by the events in the ancestral generations.

Entities:  

Mesh:

Year:  1994        PMID: 7815415      PMCID: PMC1050019          DOI: 10.1136/jmg.31.8.595

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  30 in total

1.  Genetic risks for children of women with myotonic dystrophy.

Authors:  M C Koch; T Grimm; H G Harley; P S Harper
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

2.  Genealogical reconstruction of myotonic dystrophy in the Saguenay-Lac-Saint-Jean area (Quebec, Canada).

Authors:  J Mathieu; M De Braekeleer; C Prévost
Journal:  Neurology       Date:  1990-05       Impact factor: 9.910

3.  Detection of linkage disequilibrium between the myotonic dystrophy locus and a new polymorphic DNA marker.

Authors:  H G Harley; J D Brook; J Floyd; S A Rundle; S Crow; K V Walsh; M C Thibault; P S Harper; D J Shaw
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

4.  Anticipation in myotonic dystrophy: fact or fiction?

Authors:  C J Höweler; H F Busch; J P Geraedts; M F Niermeijer; A Staal
Journal:  Brain       Date:  1989-06       Impact factor: 13.501

5.  Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene.

Authors:  M Mahadevan; C Tsilfidis; L Sabourin; G Shutler; C Amemiya; G Jansen; C Neville; M Narang; J Barceló; K O'Hoy
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

6.  Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy.

Authors:  H G Harley; J D Brook; S A Rundle; S Crow; W Reardon; A J Buckler; P S Harper; D E Housman; D J Shaw
Journal:  Nature       Date:  1992-02-06       Impact factor: 49.962

7.  Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy.

Authors:  J Buxton; P Shelbourne; J Davies; C Jones; T Van Tongeren; C Aslanidis; P de Jong; G Jansen; M Anvret; B Riley
Journal:  Nature       Date:  1992-02-06       Impact factor: 49.962

8.  Cloning of the essential myotonic dystrophy region and mapping of the putative defect.

Authors:  C Aslanidis; G Jansen; C Amemiya; G Shutler; M Mahadevan; C Tsilfidis; C Chen; J Alleman; N G Wormskamp; M Vooijs
Journal:  Nature       Date:  1992-02-06       Impact factor: 49.962

9.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

10.  High resolution genetic analysis suggests one ancestral predisposing haplotype for the origin of the myotonic dystrophy mutation.

Authors:  C E Neville; M S Mahadevan; J M Barceló; R G Korneluk
Journal:  Hum Mol Genet       Date:  1994-01       Impact factor: 6.150

View more
  3 in total

1.  Reproductive fitness in familial schizophrenia.

Authors:  A S Bassett; A Bury; K A Hodgkinson; W G Honer
Journal:  Schizophr Res       Date:  1996-09-18       Impact factor: 4.939

2.  Paternal transmission of congenital myotonic dystrophy.

Authors:  C E de Die-Smulders; H J Smeets; W Loots; H B Anten; J F Mirandolle; J P Geraedts; C J Höweler
Journal:  J Med Genet       Date:  1997-11       Impact factor: 6.318

Review 3.  Psychiatric and cognitive phenotype in children and adolescents with myotonic dystrophy.

Authors:  Marie Douniol; Aurélia Jacquette; Jean-Marc Guilé; Marie-Laure Tanguy; Nathalie Angeard; Delphine Héron; Monique Plaza; David Cohen
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-06-19       Impact factor: 4.785

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.